Christoph Müller

659 total citations
21 papers, 404 citations indexed

About

Christoph Müller is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Christoph Müller has authored 21 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Immunology. Recurrent topics in Christoph Müller's work include Toxin Mechanisms and Immunotoxins (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Silymarin and Mushroom Poisoning (6 papers). Christoph Müller is often cited by papers focused on Toxin Mechanisms and Immunotoxins (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Silymarin and Mushroom Poisoning (6 papers). Christoph Müller collaborates with scholars based in Germany, Italy and France. Christoph Müller's co-authors include Andreas Pahl, Torsten Hechler, Christian Lutz, Gunnar Sæter, Paul Noordhuis, Florence Pédeutour, Ola Myklebost, Takashi Nagano, Oliver Müller and Günter Seidel and has published in prestigious journals such as Angewandte Chemie International Edition, Blood and Cancer Research.

In The Last Decade

Christoph Müller

19 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christoph Müller Germany 11 168 144 98 91 79 21 404
Roger Y. Tsang Canada 8 135 0.8× 154 1.1× 41 0.4× 40 0.4× 48 0.6× 21 399
Ulrike Pfaar Switzerland 10 190 1.1× 201 1.4× 64 0.7× 54 0.6× 67 0.8× 12 568
Yue-Li Sun China 10 248 1.5× 230 1.6× 59 0.6× 31 0.3× 38 0.5× 23 535
Hille Gieschen Germany 12 90 0.5× 105 0.7× 219 2.2× 27 0.3× 101 1.3× 16 455
Wayne D. Brenckman United States 12 146 0.9× 147 1.0× 70 0.7× 35 0.4× 30 0.4× 15 441
Peter Nygren Sweden 11 141 0.8× 184 1.3× 54 0.6× 27 0.3× 23 0.3× 14 401
Alicja Puszkiel France 10 106 0.6× 134 0.9× 50 0.5× 30 0.3× 27 0.3× 29 304
Jean-Pierre Bizzari France 14 288 1.7× 267 1.9× 95 1.0× 66 0.7× 16 0.2× 24 515
Sarah Lowndes United Kingdom 7 114 0.7× 157 1.1× 90 0.9× 48 0.5× 32 0.4× 10 455
Maeng Sup Kim South Korea 10 201 1.2× 218 1.5× 84 0.9× 164 1.8× 30 0.4× 13 443

Countries citing papers authored by Christoph Müller

Since Specialization
Citations

This map shows the geographic impact of Christoph Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Müller more than expected).

Fields of papers citing papers by Christoph Müller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Müller. The network helps show where Christoph Müller may publish in the future.

Co-authorship network of co-authors of Christoph Müller

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Müller. A scholar is included among the top collaborators of Christoph Müller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Müller. Christoph Müller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Müller, Christoph, et al.. (2025). Replication of patient specific circulating tumor cells on a microfibrous filter for drug screening. Nanoscale. 17(18). 11592–11604.
3.
Gallo, Francesca Romana, Christoph Müller, Torsten Hechler, et al.. (2021). Enhancing the Pharmacokinetics and Antitumor Activity of an α-Amanitin-Based Small-Molecule Drug Conjugate via Conjugation with an Fc Domain. Journal of Medicinal Chemistry. 64(7). 4117–4129. 30 indexed citations
4.
Breunig, Christian, Anja Baumann, Nicola Giesen, et al.. (2020). HDP-101, an Anti-BCMA Antibody–Drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma Cells. Molecular Cancer Therapeutics. 20(2). 367–378. 61 indexed citations
5.
Lutz, Christian, et al.. (2020). Totalsynthese von α‐ und β‐Amanitin. Angewandte Chemie. 132(28). 11486–11490. 4 indexed citations
6.
Lutz, Christian, et al.. (2020). Total Synthesis of α‐ and β‐Amanitin. Angewandte Chemie International Edition. 59(28). 11390–11393. 39 indexed citations
7.
López, P., Christoph Müller, Christian Breunig, et al.. (2019). β-Glucuronidase triggers extracellular MMAE release from an integrin-targeted conjugate. Organic & Biomolecular Chemistry. 17(19). 4705–4710. 13 indexed citations
9.
López, P., Torsten Hechler, Andreas Pahl, et al.. (2018). Synthesis and biological evaluation of RGD and isoDGR peptidomimetic-α-amanitin conjugates for tumor-targeting. Beilstein Journal of Organic Chemistry. 14. 407–415. 29 indexed citations
10.
Breunig, Christian, Torsten Hechler, Christoph Müller, et al.. (2018). Abstract 740: Preclinical evaluation of an anti-PSMA antibody-targeted amanitin conjugate (ATAC). Cancer Research. 78(13_Supplement). 740–740. 1 indexed citations
11.
Breunig, Christian, Nicola Lehners, Anja Baumann, et al.. (2017). Preclinical Evaluation of Hdp-101, a Novel Anti-BCMA Antibody-Drug Conjugate, in Multiple Myeloma. Blood. 130. 3070–3070. 11 indexed citations
12.
Hechler, Torsten, et al.. (2017). Abstract 62: CD19 - a potential target for Amanitin-based ADCs. Cancer Research. 77(13_Supplement). 62–62. 2 indexed citations
13.
Hechler, Torsten, et al.. (2017). Abstract 77: Preclinical evaluation of HDP-101, an anti-BCMA antibody-drug conjugate. Cancer Research. 77(13_Supplement). 77–77. 5 indexed citations
14.
Hechler, Torsten, Christoph Müller, Andreas Pahl, & Jan Anderl. (2015). Abstract 633: Amanitin-based ADCs with an improved therapeutic index. Cancer Research. 75(15_Supplement). 633–633. 1 indexed citations
15.
Sandin, Peter, Francesca Baldelli Bombelli, Christoph Müller, et al.. (2014). Diastereoselective self-assembly of clofarabine lipids. New Journal of Chemistry. 38(11). 5247–5253. 3 indexed citations
16.
Ferreirós, Nerea, Sebastian Dresen, Maren Hermanns‐Clausen, et al.. (2009). Fatal and severe codeine intoxication in 3-year-old twins—interpretation of drug and metabolite concentrations. International Journal of Legal Medicine. 123(5). 387–394. 25 indexed citations
17.
Hermanns‐Clausen, Maren, Wolfgang Weinmann, Volker Auwärter, et al.. (2008). Drug dosing error with drops—severe clinical course of codeine intoxication in twins. European Journal of Pediatrics. 168(7). 819–824. 29 indexed citations
18.
Müller, Christoph, et al.. (2007). Potential for treatment of liposarcomas with the MDM2 antagonist Nutlin‐3A. International Journal of Cancer. 121(1). 199–205. 90 indexed citations
19.
Fürstner, Alois, Takashi Nagano, Christoph Müller, Günter Seidel, & Oliver Müller. (2006). Total Synthesis and Evaluation of the Actin‐Binding Properties of Microcarpalide and a Focused Library of Analogues. Chemistry - A European Journal. 13(5). 1452–1462. 46 indexed citations
20.
Wagner, Erin, et al.. (1967). [Ulcera perforata ventriculi sive duodeni. (Occurrence, diagnosis, treatment and results)].. PubMed. 92(23). 801–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026